American National Bank & Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WT
BHIA
NONA
SIM
AAIS
American National Bank & Trust's EW Position: Q2 2026 in Review
American National Bank & Trust held its Edwards Lifesciences (EW) position steady in Q2 2026 at 1,527 shares worth $138K. The position accounts for 0.01% of the portfolio, ranked #283.
American National Bank & Trust first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $161K in Q1 2024. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- American National Bank & Trust held 1,527 shares of Edwards Lifesciences worth $138K as of Q2 2026.
- American National Bank & Trust left its Edwards Lifesciences share count unchanged in Q2 2026.
- Edwards Lifesciences made up 0.01% of American National Bank & Trust's portfolio in Q2 2026, its #283 holding.
- American National Bank & Trust first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
- American National Bank & Trust's Edwards Lifesciences position peaked at $161K in Q1 2024.
- 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.